Security Snapshot

Alamar Biosciences, Inc. - Common Stock, par value $0.0001 per share (ALMR) Institutional Ownership

CUSIP: 010911105

13F Institutional Holders and Ownership History for Q2 2026

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$26.13

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
ALMR on Nasdaq
Shares outstanding
69,359,443
SEC-reported price per share
$26.13
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ALMR - Alamar Biosciences, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 010911105.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Latest quarter on this page is Q2 2026.
  • Additional quarter-over-quarter change detail appears as history expands.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

010911105

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

ALMR full holder history Alamar Biosciences, Inc. SEC filings Alamar Biosciences, Inc. company facts Alamar Biosciences, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
ALMR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SHERPA HEALTHCARE FUND II, L.P. 7.2% $110,331,653 4,972,134 Daqing Cai 16 Apr 2026
Sands Capital Life Sciences Pulse Fund II, L.P. 6.1% $93,884,248 4,230,926 Sands Capital Life Sciences Pulse Fund II, L.P. 05 Jul 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
1
Latest
n/a
Rows shown
1-1 of 1
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 280,549 $7,600,072 +$7,600,072 $27.09 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .